Our previous studies demonstrated that AKR1C2, an isoform of aldo-keto reductase 1C (AKR1C), was frequently detected in PCa patients and was associated with disease status, tumor grade and androgen receptor expression [5]. Here, AKR1C2 is linked to neoplasm.